Cite

    Nautiyal, K. et al. (2015). Progressive transfusion and growth factor independence with adjuvant sertraline in low risk myelodysplastic syndrome treated with an erythropoiesis stimulating agent and granulocyte-colony stimulating factor. Leukemia research reports. 4 (1), pp. 1-3. [Online].